One of the major characteristic features of Type II (non-insulin-dependent) diabetes mellitus is the decreased ability of pancreatic beta cells to release insulin in response to stimulation by the carbohydrate d-glucose, the most potent physiological insulin secretagogue. Such a disturbance in islet function occurs in the GK rat [1±7], a genetic non-overweight model of Type II diabetes which was obtained through repetitive selective inbreeding of normal Wistar rats with a plasma glucose concentration in the upper normal range, as shown by an oral glucose tolerance test [8, 9] . Even though the reasons for the Diabetologia (1999) 
deterioration in responsiveness of beta cells to the hexose in the GK rodent model remain to a large extent unclear, several site-specific lesions within islet beta cells have been described as possible contributing or causal factors for this secretory dysfunction. Among them are the underexpression of the glucose transporter 2 (GLUT-2) [4] , the wasting of ATP in a futile cycle between d-glucose and d-glucose 6-phosphate [5] and the inadequate aerobic (oxidative) glycolysis [3, 10] . The latter perturbation results from either a decrease in the mitochondrial activity of flavine adenine dinucleotide (FAD)-dependent glycerophosphate dehydrogenase and the ensuing reduced metabolic flux through the glycerol phosphate shuttle [6, 11±15] or a decrease in the pyruvate dehydrogenase activity [16] .
We previously documented further evidence that islets obtained from these spontaneously diabetic rats exhibit a reduced insulin output in response not only to d-glucose but also to the essential amino acid l-leucine [3] . This is normally a potent amino acid in promoting insulin both in vivo and in vitro and can stimulate the beta cell in the absence of extracellular glucose. This study is an attempt to explain the so far unexplored biochemical mechanisms underlying the defective beta-cell responsiveness to the amino acid in the GK rat islets.
l-leucine is known to stimulate insulin release in normal beta cells by two intramitochondrial mechanisms: firstly the own catabolism of l-leucine [17±20] and secondly the allosteric activation of glutamate dehydrogenase resulting in an acceleration of the catabolism of l-glutamate synthesized from l-glutamine Simplified representation for the mechanisms of action of l-leucine in pancreatic islet beta cells. The process by which l-leucine stimulate insulin release is thought to rely on an increase in catabolic fluxes in the islet beta cells via two main routes, first, the own catabolism of l-leucine [17±20] and second, the leucine-stimulated glutamate catabolism [20±25] . l-leucine entered the islet cells using mainly a Na + -independent transport known as system L [26, 27] . In the first pathway, the amino-acid is metabolized in the beta-cell mitochondria by first undergoing deamination to yield 2-ketoisocaproate (KIC). This reaction (transamination), catalysed by a branched-chain amino-acid aminotransferase (mentioned in the text as leucine transaminase), is coupled with the conversion of a suitable 2-keto-acid to the corresponding amino-acid (e. g. the conversion of 2-ketoglutarate to l-glutamate). Then, an oxidative decarboxylation, catalysed by the branched-chain 2-ketoacid dehydrogenase (BCKDH) multienzyme complex, convertes the deamination product of leucine, KIC, into isovaleryl-coenzyme A. This latter product is further degraded and, after several conversions, forms free acetoacetate and acetylcoenzyme A which enter the citric acid cycle (Krebs cycle) for complete oxidation to CO 2 and H 2 O. In the second pathway, l-leucine acts as an allosteric activator of glutamate dehydrogenase in beta cells. By doing so, it increases the oxidative deamination of endogenous glutamate and, hence, the formation of 2-ketoglutarate which is further oxidized in the Krebs cycle. The accelerated flux through each of these two pathways leads to an increase in necessary metabolic intermediates that govern the release of insulin, the biophysical events linking the metabolism of the exogenous or endogenous amino-acid and the exocytosis of insulin granules being similar to those involved in the response to d-glucose [28±30] [20±25]. Both mechanisms lead to an increase of the metabolic flux rate through the Krebs cycle [20] ( Fig. 1 ). These two metabolic pathways have been investigated in pancreatic islets freshly isolated from either GK rats or, as controls, Wistar rats.
Materials and methods
Animals. All the animals were adult male rats. Diabetic GK rats were obtained from our local colony initiated in Paris in 1988 [2] with progenitors issued from the 35 th generation in the original colony established by Goto and Kakizaki [8, 9] . Wistar rats raised in parallel were used as control animals. The rats were weaned 28 days after birth and then were allowed free access to tap water and a standard pelleted chow (diet 113, Rational Food Factory (Usine d'Alimentation Rationnelle), Villemoisson-sur-Orge, France) up to the time of the experiments. Experiments were carried out in accordance with the ethical rules of animal experimentation recommended by french legislation and the`principles of laboratory animal care' (NIH publication no. 85-23, revised 1995).
Blood collection and islet preparation. At the time of the experiments, the rats were weighed and killed by exsanguination, blood samples being collected in heparinized tubes. After centrifugation for 10 min at 1000 g and 4 C, the plasma was removed and stored at 20 C for further glucose and insulin determinations.
In each experiment, islets were isolated from the pancreas of 2±6 rats for each type of animal by a collagenase digestion technique [27] and subsequently separated from the remaining non-endocrine tissue by hand picking under a stereomicroscope. Collagenase produced from Clostridium histolyticum (EC 3.4.24.3, type P) was purchased from Boehringer Mannheim (Mannheim, Germany). Hanks' balanced salt solution satured with a mixture of 95 % O 2 and 5 % CO 2 was used during the isolation procedure. The freshly isolated islets were immediately used for experiments.
Leucine uptake. Uptake of l-leucine by islets was studied using an oil filtration technique as described previously [32] . Islets were preincubated for 30 min in a modified [33] KRB buffer (115 mmol/l NaCl, 5 mmol/l KCl, 1 mmol/l CaCl 2 , 1 mmol/l MgCl 2 , and 24 mmol/l NaHCO 3 ) containing 5 g/l BSA (fraction V; Sigma Chemical Co., St. Louis, Mo., USA) and equilibrated against a mixture of 95 % O 2 and 5 % CO 2 . Thereafter, islets (in groups of 12 each) were incubated for 10 min at different temperatures (5, 25 or 37 C) in 100 ml of the same buffer also containing l-[1-
14
C]leucine (10 mmol/l, 377 kBq/ml; Amersham International, Amersham, UK), together with 3 H 2 O (1.85 MBq/ml; New England Nuclear, Boston, Mass., USA) as a measure of intracellular plus extracellular volume. In a limited number of experiments, l-[1-
14 C]leucine was replaced by l-[1-
14 C]glucose (2 mmol/l, 277 KBq/ml; New England Nuclear) used as an extracellular marker, to assess islet cell volume. A layer of 150 ml silicone oil (Versilube F-50; General Electric Co., Waterford, N. Y., USA) was placed on the incubation medium. After incubation, the tubes were centrifuged (Beckman Microfuge E; Beckman Instruments, Palo Alto, Calif., USA) and the tip of the tube containing the pellet of islets was removed with a scalpel and examined for its radioactive content. After correction for the blank values found in the absence of islets (7.06 ± 0.50 nl/sample; n = 22), the apparent distribution spaces were expressed as nl/islet. Enzymatic activities. Islets were sonicated in a HEPES-NaOH buffer (10 mmol/l, pH 7.0), containing 250 mmol/l sucrose, 2 mmol/l cysteine, 2 mmol/l EDTA and 0.2 g/l BSA, to yield one islet per ml.
Leucine transaminase activity was measured by two radioisotopic procedures based on the conversion of 14 C-labelled aminoacid, per ng islet DNA and per min. When required, the readings were corrected for the value found in the presence of islet homogenate and the absence of substrate (2-ketoglutarate or l-leucine). In the first procedure based on the conversion of l-[1-
14 C]ketoisocaproate, the above-mentioned value, obtained after correction for the blank value found in the absence of both substrate and homogenate, was negligible. In the second procedure based on the conversion of 2-[1-
14 C]ketoglutarate to l-[1-
C]glutamate, such a value averaged in control and GK groups respectively 10.4 ± 1.5 and 8.1 ± 2.4 % (n = 3 in both cases) of the value obtained in the presence of both homogenate and substrate. This value reflects the transamination between the 2-[1-
C]ketoglutarate and the pool of endogenous aminoacids, as catalysed by tissue transaminases [35] .
For measuring glutamate dehydrogenase activity, an aliquot (20 ml) of a 1 : 2 dilution of the islet homogenate was mixed with the same volume of a TRIS-HCl buffer (100 mmol/l, pH 8.0) containing 50 mmol/l ammonium acetate, 2 mmol/l ADP, 0.6 mmol/l NADH, and 1.4 mmol/l 2-ketoglutarate together with a tracer amount (148 KBq/ml) of 2-[1-14 C]ketoglutarate (Amersham International). After 30 min of incubation at 37 C, the reaction was stopped by the addition of 1 ml cold water followed by the immediate separation of 14 C-labelled glutamate [35] . Readings were corrected for the value found in the presence of islet homogenate and the absence of NADH. This value obtained after correction for the blank determination measured in the absence of both homogenate and NADH averaged, in the control and GK groups, respectively 1.7 ± 0.3 and 1.3 ± 0.1 % (n = 3 in both cases) of the value measured in the presence of both homogenate and NADH.
Islet glucose, pyruvate, leucine, ketoisocaproate and glutamine metabolism. Islet oxidation of exogenous nutrients was measured as described previously [36] . Radioactive precursors were obtained from the following sources: d-[6- 14 C]pyruvate from New England Nuclear. They were used at a final concentration of 370±481 KBq/ml. Briefly, groups of 15 islets each from either control or GK rats were incubated for 120 min at 37 C in 40 ml KRB [33] containing 5 g/l BSA, the labelled substrate and non-radioactive glucose, pyruvate, leucine, ketoisocaproate or glutamine at the final concentration given in the text and figures. The incubation was stopped by adding 20 ml of a citrate-NaOH buffer (400 mmol/l, pH 4.9) containing 5 mmol/l KCN, 10 mmol/l rotenone and 10 mmol/l antimycin A. The 14 CO 2 formed by the islets was determined by liquid scintillation counting after the 14 CO 2 was trapped in 250 ml hyamine hydroxide (Packard, Downers Grove, Ill., USA) over a 60-min incubation period at 20 C. Blank incubations without islets were treated in the same way as those with islets. The blank values were substracted from the experimental values. Results were expressed by reference to the specific radioactivity of the incubation medium.
In some experiments, the acidified incubation media containing the islets were stored at 20 C and later used for measurement of their content in 14 C-labelled acidic metabolites or amino acids. For these measurements, the islets and incubation medium was mixed with 200 ml of water and then sonicated. The 14 C-labelled acidic metabolites (e. g. 2-keto isocaproate generated from l-[1-
14 C]leucine) and amino acids (e. g. alanine generated from radiolabelled pyruvate) were separated from their precursors by a chromatography method by passing the homogenate through an ion-exchange resin (Dowex 50, H + form, column), as described previously [35] . The 14 C-labelled acidic metabolites were collected from the column by washing with 3.5 ml of water. The radioactive amino acids was eluted with 2 ml of ammonium acetate (1.0 mol/l) after extensive water washing of the column. Radioactivity was determined by liquid scintillation counting.
Insulin secretion. Insulin released from freshly isolated islets was measured in a static incubation system as described elsewhere [3] . Briefly, batches of seven islets each were incubated in a shaking water bath for 90 min at 37 C in 1 ml of KRB buffer [33] containing 5 g/l BSA and equilibrated against a gas phase of 95 % O 2 and 5 % CO 2 . Test agents were added as indicated in the Results section. At the end of the incubation period, samples of the incubation medium were removed and frozen until insulin assay for quantification of the released insulin.
Immunocytochemistry and morphometric quantification of insular cells. In three separate experiments two groups of 20 islets each isolated from control rats and GK rats, respectively, were fixed for 1 h in Bouin's solution. After three rinses in PBS, the islets were pre-embedded in 3 % agarose (ref. A-6013 Sigma) at 60 C and the agarose was immediately hardened in ice for 20 min. The islet pellet thus obtained was maintained overnight in 70 % ethanol. It was then dehydrated in graded solutions of ethanol, cleared in xylene, and embedded in paraplast. Serial sections (6 mm thick) were mounted on glycerine-albumin-coated glass slides. Adjacent sections from 4±5 selected islets in each islet preparation were deparaffined, rehydrated and processed for immunocytochemical staining of beta or non-beta endocrine cells, using a technique adapted from the peroxidase indirect labelling method [37] , as described previously [38] . were used. The peroxidase activity was revealed with DAB. Quantificative evaluation was done using computer-assisted image analysis by means of an Olympus BX2 microscope connected via a colour video camera to a compact PC computer using Imagenia 2000 software (Biocom; Les Ulis, France). The area of cells positive for insulin (or glucagon plus somatostatin plus pancreatic polypeptide) as well as that of total islet cells was evaluated in each stained section. The density of beta cells or non-beta endocrine (alpha, delta and PP) cells was determined according to a stereological method by calculating the ratio between the area occupied by immunoreactive cells and that occupied by total islet cells.
Glucose, insulin and DNA measurements. Plasma glucose concentration was measured by the glucose oxidase method [39] on 10 ml plasma using a glucose analyser (Beckman Instruments).
Samples for plasma insulin determination and assessement of islet insulin secretory capacity were obtained as described above. For determination of islet insulin content, groups of 25 islets each were disrupted by sonication in 0.5 ml redistilled water. A 25 ml aliquot of the aqueous homogenate was mixed with 1.0 ml of KRB containing 5 g/l BSA. Insulin was measured by RIA using porcine [ 125 I]monoiodinated insulin (Sorin Biomedica, Antony, France) as tracer [40] , guinea-pig antiporcine insulin serum as antibody (final dilution 1 : 400 000) and purified rat insulin (Novo Nordisk, Copenhagen, Denmark) as standard. Charcoal was used to separate free from bound hormone. The method allows the determination of 0.26 ng/ml, with a coefficient of variation within and between assays of 10 %.
Islet DNA content was measured from either groups of 20 islets each kept dried at 20 C or 5 ml of the islet homogenates used for enzymatic determinations. DNA was assayed by a fluorometric method [41] adapted for islet tissue [42] using bisbenzimidazol (compound Hoechst 33258, Aldrich Chimica, Milano, Italy) as fluorochrome and calf thymus DNA (Sigma) as standard).
Presentation of results and statistical analysis. All results are expressed as the mean value (± SEM) together with the number of individual determinations (n), each collected in a distinct rat or group of islets. In all cases, the indicated number of batches of islets was obtained in at least three separate experiments. Statistical significance of differences between mean values was assessed by Student's t test for unpaired data, the differences being considered significant at p less than 0.05.
Results
Characteristics of the animals. Table 1 (upper part) shows the basic characteristics of the diabetic GK and healthy (control) Wistar rats used in this study. Although of the same age, the GK rats had a lower body weight (p < 0.001) than control animals. In the fed state, GK rats had an abnormally high plasma glucose concentration (p < 0.001), despite slightly raised insulinaemia (p < 0.02). The paired ratio between plasma insulin and glucose concentrations was not significantly decreased, however, in GK rats compared with control rats.
Characteristics of the islets. The mean DNA content of islets removed from diabetic GK rats was 79 % (p < 0.005) of that of controls but the mean insulin content represented no more than 47 % of that in control islets when expressed on a per islet basis (Table 1, lower part). Thus, when taking into account the lower DNA content of GK rat islets, the insulin content per ng of islet-DNA remained lower (p < 0.01) in diabetic rat islets than in controls. Moreover, our histological data (Table 1 , lower part) show that in islets from GK rats the beta-cell : islet surface ratio is decreased compared with control islets (p < 0.001) to an extent similar (21 %) to the islet DNA content. Our data also indicate that there is no change in the relative contribution of beta cells to total endocrine cells in GK islets. Our results were therefore, whenever possible, expressed on the basis of paired islet DNA content to correct for the differences in islet size and beta-cell population of the diabetic and control specimens.
l-leucine uptake. When islets, whether from control or GK rats, were incubated for 10 min in the presence of 14 C]glucose. Pooling all available data, such a space value was found to be similar in control and GK rat islets, averaging 4.3 ± 0.2 and 3.7 ± 0.3 nl/islet (n = 100±106), respectively ( Table 2 ). The islet intracellular volume, taken as the paired difference between the distribution spaces of C]glucose, tended to be lower in diabetic rats than control animals, averaging 2.4 ± 0.2 and 3.1 ± 0.3 nl/islet (n = 21 in both), respectively. Such a difference failed, however, to achieve statistical significance (Fig. 2) . Over 10 min of incubation at a low temperature (5 C), the space of distribution of l-[1- (Table 2) . Similar results were obtained by increasing the length of incubation from 5 to 30 min (data not shown). The distribution space of the amino acid augmented, however, as a function of the temperature. Thus, when results collected after 10 min of incubation at 5 C were com- Data are means ± SEM for the number of individual observations shown in parentheses and obtained from 3 or more separate experiments pared with those recorded in the same experiments after 10 min of incubation at either 25 or 37 C, 14 Cleucine space, expressed as a per cent of the paired 3 H 2 O space, was higher (p < 0.001) in each of the two latter than the former situation and both in control and diabetic groups ( Table 2 ). For instance, in control islets such a space represented at 25 and 37 C, 191 ± 14 and 246 ± 24 % (n = 23 in both cases) of the corresponding value found at 5 C (100 ± 17, n = 18), respectively. Essentially the same results were obtained with islets from the diabetic GK rats. Judged from the differences between l-[1-
C]leucine and l-[1-
14 C]glucose spaces, estimated within each experiment and expressed relative to the paired 3 H 2 O space, the intracellular distribution space of the amino acid was calculated (Fig. 2) . No statistically significant difference between the two experimental groups (control and diabetic) was observed, whatever the temperature of incubation.
Enzymatic activities. The activity of leucine-glutamate transaminase in islet homogenates, as expressed relative to the paired DNA content of islets and whether measured with l-[1-
14 C]leucine and 2-ketoglutarate or 2-[1-
14
C]ketoglutarate and l-leucine, failed to differ significantly in control and GK rats ( Table 3) .
The activity of glutamate dehydrogenase was also identical in islet homogenates from control and diabetic animals.
Glucose, pyruvate, leucine, ketoisocaproate and glutamine metabolism. In a first set of experiments the oxidation of glucose, leucine and glutamine was examined. In agreement with our previous observations [3, 10] the present data indicate that at a high concentration of d-glucose (16.7 mmol/l) the generation of 14 
CO 2 by islets exposed to d-[6-
14 C]glucose, which informs on the insular oxidation in the Krebs cycle of acetyl residues derived from exogenous d-glucose, is lower (p < 0.001) in GK than control Wistar rats (13.9 ± 1.6 vs 24.6 ± 2.8 pmol × 120 min 1 × islet 1 , n = 44 and 28, respectively). In the islets from GK rats a decrease of about 30 % (p < 0.05 or less) was recorded in 14 CO 2 production whether in response to 10.0 mmol/l l-[1- , n = 28, respectively). By contrast, the oxidative rate of l-[U- The second set in this series of experiments aimed at comparing the two experimental groups in their oxidation of 2-ketoisocaproate and pyruvate, these two 2-ketoacids being produced from l-leucine and d-glucose, respectively. In GK rat islets incubated in the presence of 10.0 mmol/l 2-keto[1- Table 2   Table 3 . Enzymatic activities in islet homogenates from control Wistar and diabetic GK rats , n = 31±39, in the GK and control group, respectively).
Paired expression of the above-reported rough data are shown in Figures 3 and 4 . The mean oxidative rate of l-[U-
14 C]glutamine was found similar in the two experimental groups. Pooling the data obtained in the two sets of experiments, such a rate averaged 41.0 ± 3.0 and 40.1 ± 2.9 pmol × 120 min 1 × islet 1 in the islets from control and diabetic rats, respectively (n = 49±60). To take into account the differences between islets obtained from different preparations and groups of animals and in two distinct series of experiments l-glutamine oxidation, taken as a reflection of the amount of islet-cell material present in each sample, was therefore used as a reference value within each experiment for the oxidative data. When expressed relative to such a paired reference value (Fig. 3) , the picture was exactly the same as the one mentioned above, i. e. a decreased (Fig. 4) . In the islets from GK rats, the fraction of decarboxylated leucine being oxidized was similar, with a value of 51 ± 4 % (n = 44). The proportion of pyruvate being oxidized into the Krebs cycle was also identical in the islets from control and diabetic animals averaging 58 ± 3 % (n = 39) and 55 ± 4 % (n = 31), respectively, estimated by the ratio between the yields of the In these experiments the generation of 14 C-labelled acidic metabolites in islets exposed to l-[1- C]leucine, was, however, similar (p > 0.5) in the two experimental groups, such a calculated value averaging in GK rat islets 88 ± 11 % (n = 33) of the value found in control islets (100 ± 8 %, n = 35). These results reinforce the enzymatic data suggesting that there is no alteration of the leucine transamination process in the islets of diabetic animals. In addition, the generation of radioactive amino acids, presumably mainly radioactive alanine, by islets exposed to 14 C-labelled pyruvate was similar in control and GK rat islets averaging, when expressed as pyruvate residues, 10.0 ± 0.6 (n = 75) and 11.3 ± 1.3 (n = 61) pmol × 120 min 1 × islet 1 , respectively. This suggests that the transamination reaction catalysed by alanine aminotransferase also failed to be affected in the islets of GK rats.
Lastly, the oxidation rate of l-[U-
14
C]glutamine (10.0 mmol/l) was enhanced (p < 0.001) by the presence of 10.0 mmol/l l-leucine in the incubation medium both in control and diabetic groups (data not shown). The extent of such an enhancing effect was similar in islets from GK and control rats (factor of multiplication of 1.6 ± 0.1, n = 15 and 1.7 ± 0.1, n = 18, respectively). By contrast, the addition of l-glutamine (10.0 mmol/l) upon l-[1-
C]leucine oxidation rate had no effect either in control or in GK rat islets and the presence of l-glutamine exerted an inhibitory effect on l-[U-
C]leucine oxidation both in control and GK rat islets, the inhibition being almost identical in extent in the two experimental groups. Thus, in the presence of l-glutamine the 14 
CO 2 output from l-[U-
14 C]leucine averaged in control and GK rat islets, 68 ± 9 % (n = 10) and 57 ± 11 % (n = 9), respectively, of the corresponding mean value found in the same experiments in the absence of l-glutamine (100 ± 22 % and 100 ± 36 %, respectively; n = 4 in both).
Insulin secretion. In the last series of experiments, we examined the secretory response of pancreatic islets to the major secretagogues used in the above metabolic studies, namely d-glucose, l-leucine, 2-ketoisocaproate (KIC), l-glutamine, as well as to the nonmetabolizable analogue of l-leucine, 2-amino-bicyclo[2,2,1]heptane-2-carboxylic acid (BCH).
The basal release of insulin, measured in the presence of a non-stimulatory d-glucose concentration (2.8 mmol/l) and expressed on the basis of the paired DNA content of islets to take into account the decreased beta-cell mass in the islets of GK rats, was similar in the two experimental groups, averaging 212 ± 25 and 188 ± 46 pg × 90 min 1 × ng islet DNA 1 , respectively (n = 14 in both).
In fair agreement with our previous report [3] , the islets isolated from GK rats, compared with islets removed from Wistar rats, showed a large impairment in their insulin secretory response to d-glucose as well as to l-leucine. Thus, the insulin output averaged, in control and diabetic rat islets, 1308 ± 86 and 396 ± 33 pg × 90 min 1 × ng islet DNA 1 in the presence of 16.7 mmol/l d-glucose, and 439 ± 41 and 183 ± 44 pg × 90 min 1 × ng islet DNA 1 in the presence of 10.0 mmol/l l-leucine, both respectively such differences between the two experimental groups being highly (p < 0.001) significant.
When islets are exposed to 10.0 mmol/l KIC, the output of insulin was also much lower (p < 0.01) in GK (292 ± 69 pg × 90 min 1 × ng islet DNA 1 ) than control group (498 ± 22 pg × 90 min 1 × ng islet DNA 1 ). A lack of insulin response to the immediate deamination product of l-leucine constitute, therefore, another characteristic of islets in diabetic animals.
It should be stressed that such a deficient secretory response of beta cells to these three nutrient secretagogues coincided with a lower insulin content in the beta cells of diabetic than control rats. The ratio between islet insulin output and content was, however, lower in the three cases in GK than in control rats. For instance, under l-leucine stimulation, such a ratio averaged in islets from GK rats only (p < 0.025) 69 ± 11 % (n = 14) of that recorded under the same experimental conditions in control rats (100 ± 6 %; n = 14).
By contrast, the insulin secretory response of islets to 10.0 mmol/l BCH was not statistically significantly different in GK and control rats whether the results are expressed as the absolute value (313 ± 73 and 448 ± 42 pg insulin × 90 min 1 × ng islet DNA 1 in diabetic and control rat islets, respectively), relative to the basal release measured within the same type of rats and within the same experiment (paired data) in the presence of 2.8 mmol/l d-glucose (191 ± 20 and 221 ± 15 % in diabetic and control rat islets, respectively) or as the percentage of the insulin content of islets from the same preparation (9 ± 2 and 9 ± 1 % in diabetic and control rat islets, respectively).
Islets were also exposed to the combination of lleucine with either BCH or l-glutamine (10 mmol/l each). In both experimental groups, the association l-leucine plus BCH or l-leucine plus l-glutamine increased (p < 0.005 or less) the output of insulin, compared with the paired basal release. In both cases, the insulin output remained, however, lower (p < 0.001) in the islets from diabetic (283 ± 42 and 281 ± 31 pg × 90 min 1 × ng islet DNA 1 in the presence of the combination leucine-BCH and leucineglutamine, respectively) than in control rats (635 ± 50 and 959 ± 77 pg × 90 min 1 × ng islet DNA 1 in the presence of the combination leucine-BCH and leucine-glutamine, respectively). It is known that l-glutamine alone, unlike l-leucine alone, is not insulinotropic and that it enhances the insulinotropic effect of l-leucine [23, 43] . Our data obtained in control islets clearly illustrate this enhancing action of l-glutamine upon insulin release evoked by l-leucine (Fig. 5, left panel) . They further indicate that the combination of l-leucine and BCH exerts a more potent insulinotropic effect than l-leucine or BCH alone (Fig. 5, left panel) . In the islets from diabetic GK rats, the addition of BCH or l-glu-tamine enhanced (p < 0.005 or less, paired comparison of the data) the beta-cell secretory response induced by l-leucine to the same extent as in control islets (Fig. 5, left panel) . On the contrary, addition of l-leucine, which 1.5-fold amplified (p < 0.001, paired comparison of the data) BCH-stimulated insulin output in controls, failed to elicit a statistically significant increase of the insulin output above the value found in the sole presence of BCH in the islets from GK rats (Fig. 5, right panel) .
Discussion
These data are in fair agreement with our earlier observations showing a deficient insulin output in response to both glucose and leucine in the islets from GK rats [3] . So far, most of the studies on the endocrine function of pancreas in GK rats were focused on the cellular mechanisms behind the impaired insulin response to the hexose [3±7, 10, 11, 14±16, 44±47]. The current study was the first attempt to identify the factor(s) responsible for the deficient beta-cell response to the amino acid in this model of Type II diabetes. Our results show that the insulin output evoked by KIC, the first derivative of leucine catabolism, is also reduced in the islets of GK rats. At first glance, this secretory behaviour is not surprising since it can be argued that it is associated with a decreased insulin availability in the islets. The data shown herein indicate, in accordance with our previous reports [3, 48] , that islets of GK rats originating from our colony show decreased beta-cell mass and low insulin content compared with control islets. The islet DNA content was decreased to a similar extent to that of the islet beta cells. This is consistent with our morphometric data which indicates that there is no major change in the relative contribution of beta cells to total endocrine cells in the GK rat islets. This last observation accords with results obtained with GK rats from three other colonies [4, 11, 46] . In addition, in GK rat islets the insulin content, when expressed relative to the DNA content, remains lower than in control islets which is in support of a degranulation in the beta cells of the diabetic animals [45, 49] .
This study provides, however, evidence that, even if the decreased beta-cell mass and insulin store in GK rat islets could contribute to their poor insulin secretory capacity, the failure of leucine as well as KIC to stimulate the hormonal release is also due to an impaired stimulus-secretion coupling for these secretagogues. Firstly, the insulin secretion evoked by each of these secretagogues, when expressed as a percentage of the islet insulin content, remained lower in the islets from GK than control rats. Secondly, the islet beta cells of GK rats are able to respond properly to other secretagogues such as the artificial leucine analogue BCH which, under our experimental conditions, induced an insulin output of the same magnitude as l-leucine in control islets. It should be noted that these results of the insulinotropic effect of BCH in GK rat islets, although agreeing with our previous observations [13] , are at variance with the data of another study [45] showing an impaired secretory re-A B sponse of the islets from GK rats to this secretagogue. We have no explanation for these differences, but these results were obtained in two distinct GK rat colonies. There is contradictory data on GK rats suggesting that differences in genetic or environmental conditions (e. g. colony, food, age, etc.) or both might be responsible for the differences so far reported and related to morphology [4, 11, 46, 48, 50] , insulin content of islets [3, 5±7, 10, 16, 45] or intra-islet glucose metabolism [3, 5, 6, 10] . Our observation of a disturbed KIC-induced insulin release in GK rat islets is in line with our earlier observations [12] but contradicts other data [44] . The authors of the report of that data showed with the patch-clamp technique that KIC, in contrast to glucose, closed the ATP-sensitive K + channels normally in islets isolated from GK rats and they asserted, from unpublished observations, that the enhancement of insulin secretion by this keto acid is almost identical between GK and control rat islets. Also conflicting, at first glance, with our data are the data of two reports [6, 51] showing a maintained insulin response to KIC in the islets of the diabetic animals. In the first of these two papers, it can, however, be observed when scrutinizing the results, which were obtained in the London GK rat colony, that the KIC-stimulated insulin release was approximately 30 % lower in GK rat islets than in controls, even though the difference between the two experimental groups was not found statistically significant. In the second paper, the animals used were F1-hybrid rats obtained from crosses between female Wistar and male GK rats from the Stockholm colony. In addition the authors also mentioned in the discussion section of this paper that, in contrast to hybrid rats, islet insulin release induced by KIC was found decreased in Stockholm GK rats. Lastly, our data further shows that, in GK rat islets, whereas the enhancing action of either l-glutamine or BCH upon leucine-stimulated insulin release is preserved, l-leucine addition failed to amplify BCH-stimulated insulin output as it is in controls.
Because the leucine-induced insulin release occurs partly as a consequence of the leucine metabolism within the beta cells [17±19], we made the assumption that the loss of insulin response to l-leucine in the islets from GK rats could be due to a reduced leucinemetabolism within their insular cells. Our measurements of l-[1-
14 C]leucine uptake by intact islets suggest that there is no major defect in the transport of amino acid across the plasma membrane in the islet cells of diabetic GK rats. From the two independent sets of data mentioned below, it also seems clear that the secretory failure of the beta-cell response to lleucine in the GK rat islets cannot be blamed on any anomaly in the first step of the intra-islet pathway of l-leucine metabolism, in which l-leucine is converted by a branched chain amino acid aminotransferase (transaminase) to the keto acid KIC. Firstly, leucineglutamate transaminase activity, measured in crude islet homogenates, was found identical in the diabetic and control groups. Secondly, the total generation of both 14 CO 2 and
